Skip to main content
. 2019 Jul 30;22(1):85–94. doi: 10.1038/s41436-019-0618-7

Fig. 1.

Fig. 1

Genome sequencing testing pathway for cancer and rare disease cases in the Oxford Molecular Diagnostics Center. The arrows on the right-hand side indicate the potential for stage repetition due to minor process errors.